12 completed, 6 unknown. 15 Phase 1, 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 15 | Completed 11, Unknown 4 |
| Not applicable | 3 | Unknown 2, Completed 1 |
Follow Bioequivalence Study: new trials by email Literature Review of Bioequivalence Study trials Research Report on Bioequivalence Study
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions Dabigatran Etexilate Capsules 150 mg - Healthy Volunteer, Dabigatran | Phase 1 | Unknown | International Bio service | 60 | 2024-09-25 | 2024-06-06 |
| A Pilot Bioequivalence Study of Pomalidomide Pomalidomide 4 MG Oral Capsule - Bioequivalence Study | Phase 1 | Unknown | Megalabs | 10 | 2024-09-15 | 2023-09-28 |
| Bioequivalence Study of AG2202 AG2202T, AG2202R - Bioequivalence Study | Phase 1 | Unknown | Ahn-Gook Pharmaceuticals Co.,Ltd | 34 | 2024-08-01 | 2024-08-14 |
| A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions Sacubitril and Valsartan Tablets 49mg/51mg, Entresto® (Sacubitril and Valsartan Tablets 49mg/51mg) - Bioequivalence Study | Phase 1 | Unknown | Viatris Inc. | 48 | 2024-04-01 | 2024-02-22 |
| Bioequivalence Study of Spironolactone Tablets in Healthy Subjects Spironolactone Tablets (Test), Spironolactone Tablets (Reference) - Bioequivalence Study | Phase 1 | Completed | SPH Sine Pharmaceutical Laboratories Co., Ltd. | 64 | 2023-03-22 | 2024-08-30 |
| Bioequivalence Study of Calcium Hydroxybenzene Sulphonate Dispersible Tablets in Chinese Healthy Volunteers Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g, Calcium Hydroxybenzene Sulfonate Tablets（Doxium®) 250mg - Bioequivalence Study | Not applicable | Unknown | Beijing Tongren Hospital | 56 | 2023-03-20 | 2023-04-03 |
| Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects. Dexlansoprazole - Healthy, Bioequivalence Study | Phase 1 | Completed | University of Karachi | 60 | 2021-09-18 | 2023-11-29 |
| Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects Moxifloxacin 400mg - Healthy Individuals, Bioequivalence Study | Phase 1 | Completed | University of Karachi | 38 | 2021-05-28 | 2022-09-07 |
| Bioequivalence Study of Venlafaxine Hydrochloride Sustained-Release Capsules in Chinese Healthy Volunteers Venlafaxine Hydrochloride Sustained-Release Capsules 75 mg, EFEXOR® XR - Bioequivalence Study | Not applicable | Unknown | Beijing Tongren Hospital | 28 | 2020-01-02 | 2020-01-18 |
| Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets sirolimus - Bioequivalence Study | Phase 1 | Completed | Nobelpharma | 10 | 2018-12-05 | 2019-02-25 |
| A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir Study Ravidasvir test formulation produced by Doppel, Ravidasvir reference formulation produced by EEPI - Bioequivalence Study | Phase 1 | Completed | Drugs for Neglected Diseases | 37 | 2018-06-05 | 2020-01-31 |
| Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream Clocortolone Pivalate - Bioequivalence Study | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 124 | 2018-03-02 | 2020-04-24 |
| Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day Diclofenac Sodium 140mg Medicated Plaster, Flector® topical plaster containing 180 mg of diclofenac hydroxyethylpyrrolidine equivalent to 140 mg of sodium diclofenac - Bioequivalence Study | Phase 1 | Completed | Fidia Farmaceutici s.p.a. | 52 | 2017-11-28 | 2020-10-14 |
| Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions Gefitinib Tablet 250mg of Hunan Kelun, Iressa® Tablet 250mg of AZN - Bioequivalence Study | Phase 1 | Completed | Hunan Kelun Pharmaceutical Co., Ltd. | 38 | 2016-09-08 | 2026-05-26 |
| Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules Neurogabin (Gabapentin) 400 mg capsule, Parketin (Gabapentin) 400 mg capsule - Healthy Volunteers, Bioequivalence Study | Not applicable | Completed | University of Karachi | 24 | 2013-06-28 | 2022-09-07 |
| Bioequivalence Study of Klaribact (Clarithromycin) 500 mg, Film Coated Tablet Klaribact 500 mg Clarithromycin Tablet, Klaricid 500 mg Clarithromycin Tablet - Healthy Volunteers, Bioequivalence Study | Phase 1 | Completed | University of Karachi | 24 | 2012-10-23 | 2022-09-07 |
| Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects D961H Sachet 20 mg, D961H HPMC capsule 20 mg - Bioequivalence Study | Phase 1 | Completed | AstraZeneca | 71 | 2012-05-01 | 2012-12-12 |
| Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects D961S, Esomeprazole, Buffered acetylsalicylic acid - Bioequivalence Study | Phase 1 | Completed | AstraZeneca | 77 | 2012-01-01 | 2012-04-09 |
Esomeprazole (2) · Capsules (1) · Clarithromycin (1) · Dabigatran (1) · Dexlansoprazole (1) · Diclofenac (1) · Gabapentin (1) · Gefitinib (1) · Hardness (1) · Moxifloxacin (1) · Sirolimus (1) · Spironolactone (1) · Valsartan (1) · Venlafaxine Hydrochloride (1) · clocortolone (1)
University of Karachi (4) · AstraZeneca (2) · Beijing Tongren Hospital (2) · Ahn-Gook Pharmaceuticals Co.,Ltd (1) · Drugs for Neglected Diseases (1) · Fidia Farmaceutici s.p.a. (1) · Hunan Kelun Pharmaceutical Co., Ltd. (1) · International Bio service (1) · Megalabs (1) · Nobelpharma (1) · SPH Sine Pharmaceutical Laboratories Co., Ltd. (1) · Sun Pharmaceutical Industries, Inc. (1) · Viatris Inc. (1)
Pakistan (4) · China (3) · Japan (3) · India (1) · Italy (1) · Malaysia (1) · Thailand (1) · United States (1)
Prof. Dr. Muhammad R Shah, PhD (4) · Ariya Khunvichai, Ph.D (1) · Damenthi Nair, MD (1) · M. Gowtham, MD (1) · Masanari Shiramoto (1) · Masataka Date (1) · Nicola Giordan (1) · Porranee Puranajoti, Ph. D (1) · Xiuli Zhao, Dr (1)